Home-Based Clinical Research Associate II (Australia)

Icon; Sydney, Melbourne; On-site; AUD 70,000 - 110,000; Full time

Job summary

ICON Strategic Solutions is seeking a Clinical Research Associate II for roles in Sydney or Melbourne, Australia. You will design and analyze clinical trials, interpret complex data, and contribute to innovative treatments and therapies.

The position involves conducting site qualification, initiation, monitoring, and close-out visits, ensuring patient safety, data integrity, and protocol compliance across trials. Travel up to 60% is expected.

Qualifications

• Bachelor's degree in a scientific or healthcare field.
• Minimum of 2 years of experience as a Clinical Research Associate.
• In-depth knowledge of clinical trial processes, regulations, and ICH-GCP guidelines.
• Strong organizational and communication skills, with attention to detail.
• Ability to travel at least 60% of the time and hold a valid driver’s license.
• Ability to work independently and collaboratively in a fast-paced environment.

Responsibilities

• Conducting site qualification, initiation, monitoring, and close-out visits for clinical trials.
• Ensuring protocol compliance, data integrity, and patient safety throughout the trial process.
• Collaborating with investigators and site staff to facilitate smooth study conduct.
• Performing data review and resolution of queries to maintain high-quality clinical data.
• Contributing to the preparation and review of study documentation, including protocols and clinical study reports.

Skills

Organizational skills

Communication skills

Independence & teamwork

Attention to detail

Education

Bachelor's degree in a scientific or healthcare-related field

Job description

ICON Strategic Solutions is seeking a Clinical Research Associate II for roles in Sydney or Melbourne, Australia. You will design and analyze clinical trials, interpret complex data, and contribute to innovative treatments and therapies.

The position involves conducting site qualification, initiation, monitoring, and close-out visits, ensuring patient safety, data integrity, and protocol compliance across trials. Travel up to 60% is expected.